治療用超音波の北米市場の評価：技術別、用途別、エンドユーザー別、国別、機会、予測（2018年～2032年）

北米の治療用超音波の市場規模は、2024年の6億3,743万米ドルから2032年に10億5,495万米ドルに達すると予測され、予測期間の2025年～2032年にCAGRで6.50%の成長が見込まれます。市場の成長は、がんや婦人科疾患、心疾患の患者の増加、同地域における先進の技術ソリューションの利用しやすさ、主要医療機器メーカーの強力なプレゼンス、医療インフラへの高額の投資によるものと考えられます。American Cancer Societyの推計によると、米国では2025年に約200万人の新規がん患者が報告される見込みです。

非侵襲的な治療ソリューションへの選好の高まりと技術の進歩も、市場の成長を後押ししています。治療用超音波は、組織の治癒の促進、痛みの軽減、異常組織の正確な除去などのさまざまな治療に高周波の音波を使用します。理学療法、腫瘍、心臓病、泌尿器科などで広く使用されています。非薬物療法への依存が高まっていることから、世界中のさまざまな地域で治療用超音波システムの需要が増加しています。さらに、さまざまな慢性疾患や障害の有病率の増加も市場の拡大を後押ししています。

当レポートでは、北米の治療用超音波市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 北米の治療用超音波市場に対する米国関税の影響

第4章 エグゼクティブサマリー

第5章 北米の治療用超音波市場の見通し（2018年～2032年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 技術別
    • 高密度焦点式超音波
    • 体外衝撃波結石破砕術
  • 用途別
    • 産婦人科
    • 腫瘍
    • 美容
    • 泌尿器科
    • 心臓
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 外来手術センター
    • 美容クリニック
    • その他
  • 国別
    • 米国
    • カナダ
    • メキシコ
  • 市場シェア分析：企業別（上位5社とその他）（金額）（2024年）
• 市場マップ分析（2024年）
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別

第6章 米国の治療用超音波市場の見通し（2018年～2032年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 技術別
    • 高密度焦点式超音波
    • 体外衝撃波結石破砕術
  • 用途別
    • 産婦人科
    • 腫瘍
    • 美容
    • 泌尿器科
    • 心臓
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 外来手術センター
    • 美容クリニック
    • その他

第7章 需給分析

第8章 輸入と輸出の分析

第9章 バリューチェーン分析

第10章 ポーターのファイブフォース分析

第11章 PESTLE分析

第12章 価格分析

第13章 市場力学

• 市場促進要因
• 市場の課題

第14章 市場動向と発展

第15章 規制情勢

第16章 製品の発売とイノベーション

第17章 ケーススタディ

第18章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Philips Holding USA Inc.
  • GE HealthCare Technologies, Inc.
  • Dornier MedTech America, Inc.
  • Siemens Medical Solutions USA Inc.
  • Canon Medical Systems USA, Inc.
  • Fujifilm Healthcare Americas Corporation
  • EDAP Technomed, Inc.
  • Acoustiic, Inc.
  • Shenzhen Huikang Medical Apparatus Co., Ltd.
  • INSIGHTEC Ltd.

第19章 戦略的提言

第20章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. North America Therapeutic Ultrasound Market, By Value, In USD Million, 2018-2032F
• Figure 2. North America Therapeutic Ultrasound Market Share (%), By Technology, 2018-2032F
• Figure 3. North America Therapeutic Ultrasound Market Share (%), By Application, 2018-2032F
• Figure 4. North America Therapeutic Ultrasound Market Share (%), By End-user, 2018-2032F
• Figure 5. North America Therapeutic Ultrasound Market Share (%), By Country, 2018-2032F
• Figure 6. United States Therapeutic Ultrasound Market, By Value, In USD Million, 2018-2032F
• Figure 7. United States Therapeutic Ultrasound Market Share (%), By Technology, 2018-2032F
• Figure 8. United States Therapeutic Ultrasound Market Share (%), By Application, 2018-2032F
• Figure 9. United States Therapeutic Ultrasound Market Share (%), By End-user, 2018-2032F
• Figure 10. Canada Therapeutic Ultrasound Market, By Value, In USD Million, 2018-2032F
• Figure 11. Canada Therapeutic Ultrasound Market Share (%), By Technology, 2018-2032F
• Figure 12. Canada Therapeutic Ultrasound Market Share (%), By Application, 2018-2032F
• Figure 13. Canada Therapeutic Ultrasound Market Share (%), By End-user, 2018-2032F
• Figure 14. Mexico Therapeutic Ultrasound Market, By Value, In USD Million, 2018-2032F
• Figure 15. Mexico Therapeutic Ultrasound Market Share (%), By Technology, 2018-2032F
• Figure 16. Mexico Therapeutic Ultrasound Market Share (%), By Application, 2018-2032F
• Figure 17. Mexico Therapeutic Ultrasound Market Share (%), By End-user, 2018-2032F
• Figure 18. Technology Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 19. Application Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 20. End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 21. Country Map-Market Size (USD Million) & Growth Rate (%), 2024

North America therapeutic ultrasound market is projected to witness a CAGR of 6.50% during the forecast period 2025-2032, growing from USD 637.43 million in 2024 to USD 1054.95 million in 2032. The market's growth can be attributed to the rising cases of cancer and gynecological and cardiac disorders, easy availability of advanced technological solutions in the region, strong presence of leading medical device manufacturers, and high investments in healthcare infrastructure. As per the estimates of the American Cancer Society, approximately 2 million new cancer cases are expected to be reported in the United States in 2025.

Increasing preference for non-invasive therapeutic solutions along with technological advancements are also driving the growth of the market. Therapeutic ultrasound uses high-frequency sound waves for various treatments, such as enhancing tissue healing, reducing pain, and eradicating abnormal tissues with precision. It is widely used in physiotherapy, oncology, cardiology, and urology, among others. The rising reliance on non-pharmacological treatment is creating an increased demand for therapeutic ultrasound systems in different regions across the globe. Additionally, the increasing prevalence of various chronic diseases and disorders is also propelling the market's expansion.

Strategic Collaborations Drive Market Growth

The key medical device companies in the region are focusing on strategic collaborations and partnerships in order to expand their presence in the industry. The different advantages associated with such alliances include integration of advanced imaging technologies, including machine learning and AI, into ultrasound systems, enhancing treatment outcomes and diagnostic precision. Additionally, collaborations also ensure the availability of cutting-edge medical solutions in different regions across the globe. In February 2024, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. signed an agreement with Ohio-based AEGLE MEDICAL SOLUTIONS LLC, under which the latter will be the sole distributor of Mindray's Hepatus-Series Transient Elastography Diagnostic Ultrasound systems, used for non-invasive management of liver diseases.

Technological Advancements Support Market Expansion

The increasing emphasis on technological advancements to accelerate product development, expand market reach, and augment innovations is positively influencing the expansion of the market. Technological advancements aid in integrating cutting edge technologies such as real time elastography and artificial intelligence (AI)-powered imaging, allowing medical professionals to improve treatment outcomes and diagnostic accuracy. In July 2024, Techsomed Ltd., a medical software innovator, has launched its BioTraceIO Vision and BioTraceIO Precision software in the United States, marking a significant advancement in image-guided ablation therapy. These FDA-cleared solutions are designed to enhance the precision and efficiency of liver tumor ablation procedures. BioTraceIO Vision employs AI-based technology to provide personalized treatment planning and assessment tools using standard medical imaging. Additionally, BioTraceIO Precision leverages real-time ultrasound data to offer predictive insights into post-ablation tissue damage.

Hospitals and Clinics Account for Significant Share of the Market

The dominance of the segment can be attributed to the wide range of therapeutic and diagnostic procedures offered by hospitals and clinics. These organizations are usually equipped with strong infrastructure and highly skilled professionals, allowing them to easily integrate advanced therapeutic technologies. Moreover, the high volume of specialized and routine ultrasound guided interventions in hospitals and clinics are also ensuring a steady requirement of therapeutic ultrasound devices.

Additionally, leading hospitals across the country are focusing on studying and integrating focused ultrasound therapies, providing lucrative growth opportunities to the market. For instance, in November 2023, Nicklaus Children's Health System became the third site in North America that is involved in Phase 1 clinical trial for evaluating the role of low-focused focused ultrasound in children with brain tumors in the brainstem. Such initiatives highlight the growing adoption of therapeutic ultrasound in advanced clinical settings and showcase its versatility beyond traditional applications.

United States Holds Major Market Share

The rapid expansion of the aging population, increasing reliance on advanced therapeutic solutions, strong presence of leading market players, and high accessibility to advanced technologies are driving the market's growth in the United States. As per the estimates of the Population Reference Bureau, the number of Americans that are 65 or older is expected to increase from 58 million in 2022 to 82 million by 2050. The older population requires frequent diagnostic testing, including imaging as well as prefers treatment solutions that cause the least amount of discomfort, supporting the market's expansion.

Additionally, the rising awareness about early disease diagnosis, growing preference for minimally invasive procedures and rapid expansion of portable ultrasounds and point of care systems are further propelling the market's growth in the country.

Impact of the U.S. Tariff on North America Therapeutic Ultrasound Market

Leading medical device manufacturing companies are expected to encounter significant financial strains due to these newly introduced tariffs by the United States. Major Medtech companies have also witnessed stock declines and are forced to either pass on the additional manufacturing costs on to the customers or absorb them, affecting the affordability and accessibility of such therapeutic solutions, particularly in homecare and outpatient settings, where cost sensitivity is high.

Small and medium-sized companies are expected to face the worse financial burdens as these companies often lack financial backing large companies have, resulting in market exit and reduced competitiveness, impacting product innovation.

Key Players Landscape and Outlook

The key players of the market are focused on product innovation and ensuring the availability of advanced medical and diagnostic solutions for the patient population. For instance, in October 2022, FUJIFILM Healthcare Americas Corporation received 510k clearance for its EG-740UT1 linear endoscopic ultrasound (EUS) scope that is compatible with its ARIETTA 8502 ultrasound processor. Such launches are allowing the leading players to expand their market presence as they improve clinical outcomes and streamline procedures, addressing the evolving requirements of community hospitals, academic centers, and ambulatory surgical centers. The advanced features provided by the device allow physicians to obtain, locate, and target precise and accurate tissue samples from the intended organ, streamlining treatment plans.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariff on North America Therapeutic Ultrasound Market

4. Executive Summary

5. North America Therapeutic Ultrasound Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Technology
    • 5.2.1.1. High Intensity Focused Ultrasound
    • 5.2.1.2. Extracorporeal Shockwave Lithotripsy
  • 5.2.2. By Application
    • 5.2.2.1. Gynecology and Obstetrics
    • 5.2.2.2. Oncology
    • 5.2.2.3. Aesthetics and Cosmetology
    • 5.2.2.4. Urology
    • 5.2.2.5. Cardiology
    • 5.2.2.6. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals and Clinics
    • 5.2.3.2. Ambulatory Surgery Centers
    • 5.2.3.3. Cosmetic and Aesthetic Clinics
    • 5.2.3.4. Others
  • 5.2.4. By Country
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Technology
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Country

6. United States Therapeutic Ultrasound Market Outlook, 2018-2032F*

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Technology
    • 6.2.1.1. High Intensity Focused Ultrasound
    • 6.2.1.2. Extracorporeal Shockwave Lithotripsy
  • 6.2.2. By Application
    • 6.2.2.1. Gynecology and Obstetrics
    • 6.2.2.2. Oncology
    • 6.2.2.3. Aesthetics and Cosmetology
    • 6.2.2.4. Urology
    • 6.2.2.5. Cardiology
    • 6.2.2.6. Others
  • 6.2.3. By End-user
    • 6.2.3.1. Hospitals and Clinics
    • 6.2.3.2. Ambulatory Surgery Centers
    • 6.2.3.3. Cosmetic and Aesthetic Clinics
    • 6.2.3.4. Others

All segments will be provided for all countries covered

7. Demand Supply Analysis

8. Import and Export Analysis

9. Value Chain Analysis

10. Porter's Five Forces Analysis

11. PESTLE Analysis

12. Pricing Analysis

13. Market Dynamics

• 13.1. Market Drivers
• 13.2. Market Challenges

14. Market Trends and Developments

15. Regulatory Landscape

16. Product Launches and Innovations

17. Case Studies

18. Competitive Landscape

• 18.1. Competition Matrix of Top 5 Market Leaders
• 18.2. SWOT Analysis for Top 5 Players
• 18.3. Key Players Landscape for Top 10 Market Players
  • 18.3.1. Philips Holding USA Inc.
    • 18.3.1.1. Company Details
    • 18.3.1.2. Key Management Personnel
    • 18.3.1.3. Products and Services
    • 18.3.1.4. Financials (As Reported)
    • 18.3.1.5. Key Market Focus and Geographical Presence
    • 18.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 18.3.2. GE HealthCare Technologies, Inc.
  • 18.3.3. Dornier MedTech America, Inc.
  • 18.3.4. Siemens Medical Solutions USA Inc.
  • 18.3.5. Canon Medical Systems USA, Inc.
  • 18.3.6. Fujifilm Healthcare Americas Corporation
  • 18.3.7. EDAP Technomed, Inc.
  • 18.3.8. Acoustiic, Inc.
  • 18.3.9. Shenzhen Huikang Medical Apparatus Co., Ltd.
  • 18.3.10. INSIGHTEC Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

19. Strategic Recommendations

20. About Us and Disclaimer